Inside Innovation

In an exclusive interview with Investment Reports, Marc Cummings, President and CEO of Life Science Washington, shared details on the state of the life science

The Kirkland-based company, Cardiac Dimensions, announced a $35 million Series D round with plans to grow its team and advance through U.S. clinical trials for

Following a positive release of clinical data from a phase 2b testing trial of zanidatamab, Zymeworks, based in the Pacific Northwest, has secured $350 million

Seattle-based biotech, Kineta Inc., recently completed a reverse merger with biotech Yumanity Therapeutics. Along with the merger, Kineta closed a $7.5 million private investment in

ActX, a biotech company based in Seattle, has raised $6 million in equity funding and is seeking an additional $107,000 to further its work in

Data from the 2019 U.S. Census Bureau reveals that while women make up over half of the workforce in the country, they only make up

Fred Hutch Cancer Center received an additional $1 million from the Washington Research Foundation (WRF). The grant will aid in the collaborative funding program for the advancement

BioSpace recently revealed its NextGen Bio Class of 2023, which features top life science startups in North America. The top companies were evaluated based on

Seattle-based biotech, A-Alpha Bio, is a new resident of an 11,000-square-foot office space in Belltown tower after the move from the University of Washington’s Fluke

William Canestaro, managing director of Washington Research Foundation and WRF Capital, has helped oversee the portfolios of 40 startups. He recently shared his expertise and

Following positive results in phase II of a multi-part, midstage trial for advanced and early-stage classical Hodgkin lymphoma (cHL), Seagen continues to plan to expand

Bothell-based company Athira Pharma recently presented biomarker data from the Phase I ACT-AD study at the 15th Clinical Trials on Alzheimer’s Disease conference. According to